Argent Biopharma Ltd (MGCLF)

[rushmann]

I think 2018 will end with a ton of initiatives having been completed waiting to be built upon further. As I've said, the real action begins 2019 and beyond. 2018 is a seedling year much like the last few, but the difference this year is things will begin to sprout. Rev's EOY will bury 2017 big time. It looks like Cannepil won't really get going until Q4 2018. That's fine. Let it all start to come together and in the meantime, accumulate, accumulate, accumulate!!!

MGCLF